A detailed history of Seven Bridge Financial Group, LLC transactions in Baxter International Inc stock. As of the latest transaction made, Seven Bridge Financial Group, LLC holds 8,349 shares of BAX stock, worth $272,427. This represents 0.06% of its overall portfolio holdings.

Number of Shares
8,349
Previous 9,349 10.7%
Holding current value
$272,427
Previous $312,000 1.6%
% of portfolio
0.06%
Previous 0.07%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$32.85 - $40.26 $32,850 - $40,260
-1,000 Reduced 10.7%
8,349 $317,000
Q1 2024

May 10, 2024

SELL
$37.88 - $43.77 $41,440 - $47,884
-1,094 Reduced 10.48%
9,349 $399,000
Q4 2023

Jan 22, 2024

SELL
$31.71 - $38.95 $1,902 - $2,337
-60 Reduced 0.57%
10,443 $403,000
Q3 2023

Oct 25, 2023

SELL
$37.32 - $49.29 $2,799 - $3,696
-75 Reduced 0.71%
10,503 $396,000
Q2 2023

Jul 26, 2023

SELL
$39.98 - $47.68 $7,995 - $9,536
-200 Reduced 1.86%
10,578 $481,000
Q1 2023

Apr 20, 2023

SELL
$37.58 - $52.57 $1,503 - $2,102
-40 Reduced 0.37%
10,778 $437,000
Q4 2022

Jan 26, 2023

SELL
$49.7 - $57.71 $2,137 - $2,481
-43 Reduced 0.4%
10,818 $0
Q3 2022

Oct 17, 2022

BUY
$53.86 - $66.8 $584,973 - $725,514
10,861 New
10,861 $585,000
Q1 2020

Apr 16, 2020

SELL
$71.57 - $93.3 $175,632 - $228,958
-2,454 Closed
0 $0
Q2 2019

Jul 15, 2019

SELL
$73.44 - $82.41 $16,524 - $18,542
-225 Reduced 8.4%
2,454 $201,000
Q4 2018

Feb 14, 2019

BUY
$61.45 - $77.8 $16,284 - $20,617
265 Added 10.98%
2,679 $176,000
Q3 2018

Nov 14, 2018

SELL
$70.71 - $77.75 $23,475 - $25,813
-332 Reduced 12.09%
2,414 $186,000
Q2 2018

Aug 14, 2018

BUY
$63.43 - $75.41 $12,686 - $15,082
200 Added 7.86%
2,746 $203,000
Q2 2017

Aug 14, 2017

BUY
N/A
2,546
2,546 $155,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.4B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Seven Bridge Financial Group, LLC Portfolio

Follow Seven Bridge Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Bridge Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seven Bridge Financial Group, LLC with notifications on news.